Ryoko Sakai

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Trends in Spontaneous Adverse Event Reports Following the Expansion of Pembrolizumab Indications in Japan

Trends in Spontaneous Adverse Event Reports Following the Expansion of Pembrolizumab Indications in Japan

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: May 06, 2026

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database.

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database.

Journal: Journal of diabetes investigation

Published: March 27, 2026

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

Factors associated with subsequent fractures post-hospital discharge for hip fracture: A single institution, retrospective cohort study.

Factors associated with subsequent fractures post-hospital discharge for hip fracture: A single institution, retrospective cohort study.

Journal: JAR life

Published: March 05, 2026

Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database.

Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database.

Journal: Arthritis research & therapy

Published: December 07, 2025

Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.

Societal cost-of-illness analysis of self-injection of biologics for patients with rheumatoid arthritis in Japan using claims, surveys, and national statistics.

Journal: Health economics review

Published: September 19, 2025

Support for patients with rheumatoid arthritis provided by care and welfare professionals in Japan: a cross-sectional study.

Support for patients with rheumatoid arthritis provided by care and welfare professionals in Japan: a cross-sectional study.

Journal: Modern rheumatology

Published: July 18, 2025

Awareness of social insurance, welfare systems, and home medical care among rheumatologists in Japan: a cross-sectional study.

Awareness of social insurance, welfare systems, and home medical care among rheumatologists in Japan: a cross-sectional study.

Journal: Modern rheumatology

Published: July 18, 2025

Economic Impact of Self-Injected Biologics for Rheumatoid Arthritis in Japan: A Propensity Score-Matched Analysis From a Public Healthcare Payer Perspective.

Economic Impact of Self-Injected Biologics for Rheumatoid Arthritis in Japan: A Propensity Score-Matched Analysis From a Public Healthcare Payer Perspective.

Journal: Value in health regional issues

Published: May 21, 2025

Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan.

Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan.

Journal: Therapeutic innovation & regulatory science

Published: May 16, 2025

Vancomycin-associated acute kidney injury and its clinical and economic impact: a retrospective cohort study using two Japanese healthcare databases.

Vancomycin-associated acute kidney injury and its clinical and economic impact: a retrospective cohort study using two Japanese healthcare databases.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: April 15, 2025

Comparison of the risk of hospitalized infections between self-injecting and non-self-injecting biologics in patients with rheumatoid arthritis.

Comparison of the risk of hospitalized infections between self-injecting and non-self-injecting biologics in patients with rheumatoid arthritis.

Journal: Modern rheumatology

Published: April 10, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026